Five-Coordinate Aluminum Amides
Organometallics, Vol. 15, No. 21, 1996 4421
round bottom flask, and 100 mL of dry THF was added. The
solution was stirred at 25 °C for 12 h, after which the solvents
were removed in vacuo to give a dark tan solid. The solid was
extracted in CH2Cl2, the solution was filtered, and CH2Cl2 was
removed in vacuo to give a yellow-orange solid (5.86 g, 87%):
Mp 277-279 °C (dec); 1H NMR (270 MHz, CDCl3) δ -0.07 (s,
18H, SiCH3), 2.48 (s, 6H, CH3), 3.76 (m, 2H, NCH2), 4.30 (m,
2H, NCH2), 6.64-7.57 (m, 8H, Ph-H); 13C NMR (100 MHz,
CDCl3) δ 2.5 (SiCH3), 4.9 (SiCH3), 17.2 (CH3), 48.0 (NCH2),
115.8 (Ph), 120.3 (Ph), 123.9 (Ph), 129.2 (Ph), 134.7 (Ph), 165.2
(Ph), 174.6 (CdN); 27Al NMR (104.15 MHz, CDCl3) δ 43 (W1/2
) 2600); IR (KBr) 2953 (m), 1606 (vs), 1447 (s), 1248 (s), 937
(s), 885 (vs), 833 (vs), 754 (vs), 474 (s) cm-1. Anal. Calcd for
CHCH3), 1.35 (s, 18H, CCH3), 1.58 (s, 18H, CCH3), 2.42 (br s,
1H, NH), 2.81 (m, 2H, CHCH3), 3.53 (m, 4H,NCH2), 6.62 (t,
1H, Ph-H), 6.83 (d, 2H, Ph-H), 7.06 (d, 2H, Ph-H), 7.59 (d, 2H,
Ph-H), 8.28 (s, 2H, NCH); 13C NMR (100 MHz, CDCl3) δ 22.9
(CHCH3), 27.5 (CHCH3), 29.8 (CCH3), 31.5 (CCH3), 34.1
(CCH3), 35.7 (CCH3), 55.9 (NCH2), 117.1 (Dipp), 118.7 (Ph-
ligand), 122.0 (Dipp), 127.0 (Ph-ligand), 130.0 (Ph-ligand),
138.3 (Ph-ligand), 139.4 (Dipp), 141.3 (Ph-ligand), 147.4 (Dipp),
163.3 (Ph-ligand), 169.5 (NCH); 27Al NMR (104.15 MHz,
CDCl3) δ 43 (W1/2 ) 3000 Hz); IR (KBr) 3360, 2953, 1626, 1554,
1460, 1390, 1261, 1177, 839, 754, 583 cm-1. Anal. Calcd for
C
44H64N3O2Al: C, 76.19; H, 9.24; N, 6.06. Found: C, 75.93;
H, 8.99; N, 5.34.
Sa len (tBu )AlNMe2 (10). Salen(tBu)AlCl (0.500 g, 0.91
mmol) was suspended in 10 mL of toluene and stirred at 25
°C, and then lithium dimethylamide (0.048 g, 0.94 mmol) was
added as a solid. The solution was stirred at 35 °C for 24 h
and filtered, and the volatiles were removed under reduced
pressure to give 0.496 g of an orange solid (98%): Mp 172 °C
C
24H36N3O2AlSi2: C, 60.20; H, 6.93; N, 8.42. Found: C, 59.88;
H, 7.48; N, 8.73.
Sa len (tBu )AlNHtBu (7). tert-Butylamine (1.0 mL, 9.45
mmol) was dissolved in 20 mL of THF and stirred at -78 °C,
t
and then BuLi (5.5 mL, 1.72 M in pentane, 9.46 mmol) was
added. The solution was warmed to 25 °C, stirred for 4 h, and
then cannulated onto a suspension of Salen(tBu)AlCl (4.95 g,
8.95 mmol) in 50 mL of toluene. The solution changed from a
yellow to orange during the course of the addition and was
stirred for 12 h. The volatiles were removed in vacuo, the
orange solid was extracted in CH2Cl2, the solution was filtered,
and the solvent was removed under reduced pressure to
provide 7 as an orange solid (4.38 g, 83%): Mp 258-261 °C;
1H NMR (270 MHz, CDCl3) δ 1.16 (s, 9H, NCCH3), 1.32 (s,
18H, CCH3), 1.56 (s, 18H, CCH3), 3.76 (m, 2H, NCH2), 4.16
(m, 2H, NCH2), 7.07 (d, 2H, Ph-H), 7.58 (d, 2H, Ph-H), 8.40 (s,
2H, NCH); 13C NMR (100 MHz, CDCl3) δ 29.8 (CCH3), 31.5
1
(dec); H NMR (270 MHz, CDCl3) δ 1.28 (s, 18H, CCH3), 1.51
(s, 18H, CCH3), 2.09 (br s, 3H, NCH3), 2.61 (s, 3H, NCH3), 4.01
(m, 4H, NCH2), 7.03 (s, 2H, Ph-H), 7.52 (s, 2H, Ph-H), 8.37 (s,
2H, NCH); 13C NMR (100 MHz, CDCl3) δ 29.7 (CCH3), 31.4
(CCH3), 34.1 (CCH3), 35.6 (CCH3), 39.1 (NCH3), 43.3 (NCH3),
54.2 (NCH2), 118.5 (Ph), 127.9, 131.5, 138.8, 140.7, 163.0, 170.8
(NCH); 27Al NMR (104.15 MHz, CDCl3) δ 45 (W1/2 ) 4500 Hz);
IR (KBr) 2955, 1651, 1628, 1541, 1442, 1257, 1175, 1026, 839,
599, 498 cm-1. Anal. Calcd for C34H52N3O2Al: C, 72.73; H,
9.27. Found: C, 72.74; H, 9.36.
Sa len (tBu )AlNEt2 (11). Salen(tBu)AlCl (1.703 g, 3.08
mmol) was suspended in 20 mL of toluene and stirred at 25
°C, and then lithium diethylamide (0.279 g, 3.36 mmol) was
added as a solid. The solution was stirred at 35 °C for 48 h
and filtered, and the volatiles were removed under reduced
pressure to give 1.632 g of an orange solid (90%): Mp 262-
264 °C (dec); 1H NMR (270 MHz, CDCl3) δ 1.10 (t, 6H,
CH2CH3), 1.28 (s, 18H, CCH3), 1.55 (s, 18H, CCH3), 2.64 (br
q, 4H, NCH2CH3), 3.92 (br s, 4H, NCH2), 7.05 (s, 2H, Ph-H),
7.56 (s, 2H, Ph-H), 8.38 (s, 2H, NCH); 13C NMR (100 MHz,
CDCl3) δ 15.5 (CH2CH3), 29.8 (CCH3), 31.4 (CCH3), 34.1
(CCH3), 35.7 (CCH3), 44.0 (NCH2CH3), 54.8 (NCH2), 118.3 (Ph),
127.3, 131.4, 139.0, 141.3, 163.0, 170.4 (NCH); 27Al NMR
(104.15 MHz, CDCl3) δ 55 (W1/2 ) 6500 Hz); IR (KBr) 2953,
2908, 2868, 1622, 1541, 1439, 1314, 1258, 1175, 1018, 854, 752,
578 cm-1. Anal. Calcd for C36H56N3O2Al: C, 73.34; H, 9.51;
N, 7.13. Found: C, 73.67; H, 9.43; N, 6.89.
(CCH3), 32.6 (NCCH3), 34.1 (CCH3), 35.7 (CCH3), 54.8 (NCH2),
27
118.3 (Ph), 127.3, 131.5, 139.0, 141.3, 163.0, 170.5 (NCH);
-
Al NMR (104.15 MHz, CDCl3) δ 56 (W1/2 ) 6800 Hz); IR (KBr)
3243, 2857, 1633, 1622, 1446, 1301, 1168, 1055, 873, 754, 598,
498. Anal. Calcd for C36H57N3O2Al: C, 73.22; H, 9.66; N, 7.11.
Found: C, 72.74; H, 9.73; N, 7.41.
Sa len (t Bu )AlNHP h (8). Aniline (0.174 mL, 1.91 mmol)
was combined with 20 mL of hexane and stirred at 25 °C, and
t
then BuLi (1.1 mL, 1.80 M in pentane, 1.98 mmol) was added
to produce a milky white suspension, which was stirred for 5
min and then cannulated onto a suspension of Salen(tBu)AlCl
(1.06 g, 1.92 mmol) in 20 mL of toluene. The solution changed
from a yellow to orange during the course of the addition and
was stirred for 3 h and filtered, and the volatiles were removed
in vacuo to provide 8 as a pale yellow solid (1.13 g, 97%): Mp,
turned orange at 190 °C and then melted while turning dark
red at 254-256 °C; 1H NMR (270 MHz, CDCl3) δ 1.35 (s, 18H,
CCH3), 1.52 (s, 18H, CCH3), 3.01 (br s, 1H, NH), 3.64 (m, 2H,
NCH2), 3.97 (m, 2H, NCH2), 6.07 (d, 2H, Ph-H), 6.28 (t, 1H,
Ph-H), 6.77 (t, 2H, Ph-H), 7.09 (d, 2H, Ph-H), 7.58 (d, 2H, Ph-
H), 8.37 (s, 2H, NCH); 13C NMR (100 MHz, CDCl3) δ 29.5
(CCH3), 31.2 (CCH3), 33.9 (CCH3), 35.4 (CCH3), 55.4 (NCH2),
113.2 (Ph-amide), 116.4 (Ph-amide), 116.5 (Ph-amide), 118.4
(Ph-ligand), 127.1 (Ph-ligand), 128.8 (Ph-amide), 131.1 (Ph-
ligand), 138.6 (Ph-ligand), 141.5 (Ph-ligand), 154.1 (Ph-amide),
163.4 (Ph-ligand), 170.2 (NCH); 27Al NMR (104.15 MHz,
CDCl3) δ 42 (W1/2 ) 1100 Hz); IR (KBr) 3360, 2859, 1649, 1622,
1442, 1301, 1177, 1056, 874, 755, 755, 598, 498, 434 cm-1. Anal.
Calcd for C38H52N3O2Al: C, 74.88; H, 8.54; N, 6.90. Found:
C, 74.66; H, 8.51; N, 7.22.
Sa len (tBu )AlNHDip p (9). 2,6-Diisopropylaniline (0.380
mL, 2.02 mmol) was combined with 20 mL of hexane and
stirred at 25 °C, and then nBuLi (0.85 mL, 2.5 M in hexane,
2.13 mmol) was added to produce a milky white suspension
which was stirred for 10 min and then cannulated onto a
suspension of Salen(tBu)AlCl (1.134 g, 2.05 mmol) in 20 mL
of toluene. The solution changed from a yellow to orange
during the course of the addition and was stirred for 10 h and
volatiles removed in vacuo. Dissolution of the residue in 40
mL of toluene, followed by filtration, and removal of volatiles
in vacuo provided 9 as a pale yellow solid (1.326 g, 95%): Mp
283-289 °C (dec); 1H NMR (270 MHz, CDCl3) δ 0.81 (d, 12H,
Sa len (tBu )AlN(SiMe3)2 (12). Salen(tBu)AlCl (0.738 g, 1.38
mmol) was suspended in 10 mL of toluene and stirred at 25
°C, and then lithium hexamethyldisilazane (0.252 g, 1.51
mmol) was added as a solid. The solution was stirred at 35
°C for 48 h and filtered, and the volatiles were removed under
reduced pressure to give 0.944 g of a fluorescent yellow solid
(99%): Mp 201-210 °C (dec); 1H NMR (270 MHz, CDCl3) δ
-0.03 (s, 18H, SiCH3), 1.29 (s, 18H, CCH3), 1.45 (s, 18H,
CCH3), 3.49 (m, 2H, NCH2), 4.35 (m, 2H, NCH2), 6.94 (d, 2H,
Ph-H), 7.48 (d, 2H, Ph-H), 8.10 (s, 2H, NCH); 13C NMR (100
MHz, CDCl3) δ 5.09 (SiCH3), 29.9 (CCH3), 31.2 (CCH3), 33.7
(CCH3), 35.2 (CCH3), 53.1 (NCH2), 118.9 (Ph), 127.0, 130.9,
137.8, 140.9, 163.6, 169.5 (NCH); 27Al NMR (104.15 MHz,
CDCl3) δ 45 (W1/2 ) 2100 Hz); 29Si NMR (CDCl3) δ -3.5; IR
(KBr) 2961, 1655, 1624, 1421, 1259, 916, 885, 754, 573 cm-1
.
Anal. Calcd for C38H64N3O2AlSi2: C, 67.16; H, 9.43; N, 6.19.
Found: C, 66.76; H, 8.96; N, 6.34.
Sa len (tBu )AlOH (13). Compound 13 can be prepared by
allowing a solution of 7-12 to stir, without heating, in air for
12 h. It is isolated as a pale yellow solid after removal of the
solvent under vacuum: Mp 310 °C (dec); 1H NMR (270 MHz,
CDCl3) δ 1.30 (s, 18H, CCH3), 1.32 (s, 18H, CCH3), 1.52 (br s,
1H, OH), 3.15 (m, 2H, NCH2), 3.30 (m, 2H, NCH2), 6.87 (d,
2H, Ph-H), 7.34 (d, 2H, Ph-H), 7.86 (s, 2H, NCH); 13C NMR
(100 MHz, CDCl3) δ 29.6 (CCH3), 31.6 (CCH3), 34.0 (CCH3),
35.6 (CCH3), 54.9 (NCH2), 118.7 (Ph), 126.2, 129.0, 136.8,